Additionally, emerging investigations have shown that CRC-derived EVs carrying miR-181a-5p can trigger the activation of hepatic stellate cells (HSCs) into cancer-associated fibroblasts (CAFs) by targeting SOCS3 and stimulating the IL-6/STAT3 pathway. Here, STAT3 is linked to cancer.